Company Overview: Our mission at LIYEN Inc. is to create empowering 'life devices.' With our first product, the SLYDER, we aim to start a revolution of empowerment for asthmatics by innovating the inhaler, while infusing beautiful aesthetic design and usability. At LIYEN, we view the overlooked, everyday medical devices as 'consumer goods' that should be wanted as much as needed by the end user. We place great emphasis in incorporating this desire driven philosophy into the design of our products. This is why the SLYDER doesn't resemble an inhaler, but has the look and feel of an iPhone. This guiding philosophy in our product development allows us to create devices that users not only depend on to manage their condition, but connect with on an emotional level while providing a sense of confidence and empowerment.

Future Growth Plans: Currently, we are focusing on bringing our novel inhaler device, the SLYDER, to market. We will initially develop our product at the Bio Innovations Gateway while focusing on Utah and the Intermountain West as our primary market. After product validation, we will expand into the national market and seek to establish larger manufacturing here locally. We will also obtain our CE mark, market test, and expand into parts of Europe in the future. We also have plans of expanding our product portfolio into other respiratory products, and various diabetic devices.

Major Accomplishments: Received top honors at the 2012 Bench 2 Bedside medical device competition at the U of U. Filed provisional patent. Successfully developed proof of concept prototype, and are currently developing a bench prototype for focus group testing.

Company Overview: Knudra is two companies based on the same core technology. Knudra Transgenics is a custom manufacturing service company bioengineering model organisms as research tools. Knudra Diagnostics discovers toxicology tools and platforms for use in pharmaceutical drug discovery.

Company Overview: Our mission at LIYEN Inc. is to create empowering 'life devices.' With our first product, the SLYDER, we aim to start a revolution of empowerment for asthmatics by innovating the inhaler, while infusing beautiful aesthetic design and usability. At LIYEN, we view the overlooked, everyday medical devices as 'consumer goods' that should be wanted as much as needed by the end user. We place great emphasis in incorporating this desire driven philosophy into the design of our products. This is why the SLYDER doesn't resemble an inhaler, but has the look and feel of an iPhone. This guiding philosophy in our product development allows us to create devices that users not only depend on to manage their condition, but connect with on an emotional level while providing a sense of confidence and empowerment.

Future Growth Plans: Currently, we are focusing on bringing our novel inhaler device, the SLYDER, to market. We will initially develop our product at the Bio Innovations Gateway while focusing on Utah and the Intermountain West as our primary market. After product validation, we will expand into the national market and seek to establish larger manufacturing here locally. We will also obtain our CE mark, market test, and expand into parts of Europe in the future. We also have plans of expanding our product portfolio into other respiratory products, and various diabetic devices.

Major Accomplishments: Received top honors at the 2012 Bench 2 Bedside medical device competition at the U of U. Filed provisional patent. Successfully developed proof of concept prototype, and are currently developing a bench prototype for focus group testing.

Company Overview: Knudra is two companies based on the same core technology. Knudra Transgenics is a custom manufacturing service company bioengineering model organisms as research tools. Knudra Diagnostics discovers toxicology tools and platforms for use in pharmaceutical drug discovery.